Prestige Consumer Healthcare Inc.
PBH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,059 | $3,951 | $4,272 | $3,873 |
| - Cash | $119 | $140 | $98 | $51 |
| + Debt | $48 | $1,043 | $1,044 | $1,027 |
| Enterprise Value | $2,988 | $4,854 | $5,219 | $4,849 |
| Revenue | $274 | $250 | $297 | $290 |
| % Growth | 9.9% | -15.9% | 2.2% | – |
| Gross Profit | $154 | $135 | $176 | $161 |
| % Margin | 56.2% | 54.2% | 59.2% | 55.5% |
| EBITDA | $87 | $80 | $92 | $98 |
| % Margin | 31.7% | 31.9% | 31% | 33.9% |
| Net Income | $42 | $47 | $50 | $61 |
| % Margin | 15.4% | 19% | 16.9% | 21% |
| EPS Diluted | 0.86 | 0.95 | 1 | 1.22 |
| % Growth | -9.5% | -5% | -18% | – |
| Operating Cash Flow | $57 | $79 | $62 | $65 |
| Capital Expenditures | -$2 | -$1 | -$3 | -$2 |
| Free Cash Flow | $55 | $78 | $58 | $64 |